Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From same article....
Anothe penny play worth watching, and maybe worth buying on the dips.
I have three patents myself. I am familiar with the process.
I am in charge of the no spin section. Most others here are intentionally misleading or delusional.
good luck next week, lets' see what happens the week after that.
:)
Sorry, didn't really see it as a REAL question but I will give you a real answer. Sure, I believe that it might be a good day to pick up some MCET, if you are confident that the patent news will be received like it was last time.
And all you want is to do is play a little spike.
I am not 100% sure it will happen, the market doesn't always work that way.
I actually think that MCET has some potential, over the long term. They have nothing that will generate any meaningful revenue in the immediate future except perhaps some liver test kits for the research market. The ADME/TOX products did nothing though.
There is nothing that will have any value clinically in the next couple of years except perhaps for MCET-125.
Stem cells? 5-10 years out, they have no proven utility for their patents.
However, if all you care about is what might happen next week, by all means, roll the dice!
There is no doubt there are another 500 million shares on the way at some point in time. Maybe another 100 million of them right when MCET hits .025. Better be quick!
Now, how about my questions?
Nobody cares, that's fine with me.
OMG! Look at that chart! Amazing! You would have to be a maroon to not put every penny you have in MCET1 50 cents by friday, the most amazing patent news coming!
Up in the GREEN section!
Hooray!
Can't miss!
Why, just look at today!
Well, good. At least we know facts are not important, just the impression that the patent, related to the stent, will have on day trading investors who will fuel the run up, and be left holding the bag. I have a little skin in the game, very little, as it might not work out the way you think.
Then again it might. Many a slip twixt the cup and lip.
Good luck next week!
Spin? Assignee; Rhode Island Hospital, Inventor; Ron Faris.
Press release: world wide license on U.S. patent.
how is that spin?
Right there in black and white. read it, right there on the patent. How is it confusing?
Look at the patent itself. Inventor: Dr. Ron Faris (used to have an association with MCET)
Assignee: Rhode Island Hospital.
it is right there in black and white.
Also, note the MCET press release. They don't specifically state that they were awarded the patent, they state they have a world wide license, on a U.S. patent.
Fundamentally that is misleading. A worldwide license cannot be granted on a patent that only applies in the U.S. the license is meaningless everywhere but in the U.S.. It means nothing in Europe, where of course whatever things MCET is going to use to treat people for unknown, not specified diseases will be approved first.
right?
When this hits .50 cents MCET will have a market cap of $600 million (with 1.2 billion outstanding shares). I can wait. You really think that will happen in 5 years or less?
Market cap right now is $7 million. The average clinical trial costs $100 million to run, that's just one.
BTW, people were posting the exact same thing 6 years ago. What has changed since then?
A few patents perhaps. Giving away the ADME/TOX rights to Corning, their only real hope of revenue.
$16K revenue last quarter, not enough to pay the rent and electricity. The "stem cell patent" which you should not forget is actually owned by Rhode Island Hospital and the terms of the licensing agreement unknown.
Sorry, don't mean to bust your bubble.
"If wishes were horses then dreamers would ride"
O.K., which drug is getting approved in europe first?
Ah, MCET smells like money, I just know it!
That is about as good an analysis as can be offered.
Well, that's where the problem comes in doesn't it? Everybody can just "speculate' as to what that value really is.
I will ask again though, what is the product that MCET has closest to bringing to market?
The ADME/TOX stuff was given to Corning to no avail. They have some other liver test kits I suppose for the research market that will be out by the end of the year they said?
What is the clinically relevant product they have closest to market?
Near as I can tell MCET-125, phase IIB hasn't even begun yet. 4-6 years to market. Phase IIB will take a year, phase II 2 years, 2 years for applications to FDA and approval.
How close is their "stem cell patent' to demonstrating even any usefulness? Much less revenue?
Until then MCET is going to be driven purely by speculation and day traders who have no clue of the science involved. Thats O.K. with me.
Each "patent" PR will be followed by a spike and then a drop.
If you go back 5-6 years and look at the message board posts they are full of the same sort of stuff. But at that time the PPS was .20 cents a share.
Those who ignore history are doomed to repeat it.
FDA approval for what?
The closest thing they have is MCT-125 which has a promising phase IIA trial. It needs more trials. I thought that they had one set up and running in the U.K. but they have just retained a group to do it, they have not funded it to the best of my knowledge. it just sits there.
Anti-cancer drug? They have the in vitro studies starting in flasks targeting liver cancer. They did the same thing with breast cancer 6 years ago and nothing came of it. At least they have some animal data for safety, but I don't seem to be able to find it.
Liver stem cells? They have a patented method for identification and isolation. Nowhere do they show any proliferative data. Can they really take one cell and make a whole liver. At this point in time I don't think so.
The stent? They already have some patents on it, bought the IP at a foreclosure sale. That tells me the worth of it. New patents will maybe give a nice little spike from those who don't understand, but the stent has not even begun any development work. It is many years from FDA approval.
FDA approval for what? Two years is quite optimistic. Generally FDA approval is at least two years from the completion of any phase III trials, with stellar results.
In the meantime I am impressed that the market absorbed 100 million shares without blinking. We will see what the next 500 million do.
Another poster stated that they authorized the shares but weren't going to need to issue them since MCET's position was so strong. You can see already that is incorrect. Revenue last quarter was $16K.
I can understand the anticipation and excitement of "a run" but I still dont' see anything of substance to support a higher PPS after that.
I rest my case...
:)
Hopefully the funnist thing youhave herd.
We shall see.
500 million shares to go.
well, certainly the hard part about a stock like MCET is not to determine what it's real value is or should be but to determine what value is placed upon it by "the market", that is, the sometimes somewhat unsophisticated, lacking in bio savvy day trader who sees the words "stem cell patent" and immediately thinks that the stock is going "to da moon!" and that big pharma has nothing but big bags o cash to hand out to anybody with a "stem cell patent".
Never mind that, for example, the patent in question is not actually held by MCET but by Rhode Island Hospital. I am sure somebody here has details on the licensing terms? I can't find any.
I didn't say that the patents were not of value, I said that their immediate value was undetermined. I most heartily agree that IP is basically all MCET has of value at this time. Unfortunately the value of the IP right now is to mainly fuel speculative pumps and dumps.
It is unfortunate that MCET gave away the rights of their liver cells for ADME/TOX to Corning who seems to be doing nothing with them. That is a good market and the reason that I invested in MCET in the first place.
100 million shares at a penny a share just about covers their losses for last year. I think MCET has potential but unfortunately a lot of it is mis-represented specifically on the Yahoo board.
And Mr.
"I have 38 years of health science experience avoiding the people that claim they know everything; the same people that are killing millions of patients every year. "
Millions? Really? And MCET will save them?
I clearly know nothing. Please tell me;
1) the drug or product MCET has closest to market and the expected revenue?
2) Which of the patents either held by MCET or licensed by them has the most value?
3) What are the specific target diseases of MCET's programs?
Or, is simply "meeting unmet medical needs" enough to make a company billions?
Let's also keep in mind that big pharma, like Astra Zeneca for example is shedding a lot of research groups and selling divisions, like animal health. They may be looking for new ways to enrich their drug portfolios but they are not as flush with cash as you might think and they are not throwing big ole bags o cash at any company with a few patents and a live body to answer the phone.
I hope this post replaces my other one as the "the funnist thing ihave herd."
Good luck with the big run up next week! Going to a buck a share for sure!
O.K., $billions if you say so. I may not know squat didley about the pharmaceutical business, I just own a biotech company, but I do at least know how to spell it. Pie in the sky dreams for a company with $16K in revenue last quarter are just that.
I am surprised that the pps has held given the extra shares out. That must explain a couple of the big volume days. The market can suck up a 100 millions shares, but not budge the share price, which is still a good thing.
I know you are all excited about the upcoming patents. something doesn't smell right to me, why the published notice from the PTSO before the PR? Not only is it in the mail they should have it by now. From reading the patents they are related to the stent, filed in 2003, they must have put some work into it. I am not necessarily a hater, I just don't like misleading posts, and there have been plenty with MCET. I don't see these patents as having any real importance to the value of MCET at this time. Trials for the stent are a ways off. It may have value as simply another excuse to pump and dump.
"MCET owns another patent!"
"All these patents means MCET is worth Billions!"
Do keep in mind that the assignee on the original patent application was Polymerix and that somehow got transferred to Xenogenix.
Note I said "at this time". Maybe they are waiting to get the IP locked up before they do any more development work on it. I do know that there is at least one other company getting out of the stent business.
just noticed the outstanding shares as listed on TD Ameritrade are 767.9 million as opposed to the 647.2 million listed on Yahoo. Seems like that happened in the just last day or two....
ha! :)
The abstract:
"Medical devices with at least one surface comprising a polymer or polymers on the surface are provided. The polymer or polymers are capable of breaking down (e.g., including, but not limited to, hydrolyzing) in the physiologic milieu to form an active agent or agents under physiologic conditions, and can contain other active agents dispersed within or appended to the polymer matrix. Methods of delivering an active agent to an interior surface of a vein or artery are also provided."
Says the assignee is Polymerix corp but that is on the application, it may have changed.
without going back and looking you might be right. the patent on the stent is a two drug resorbable stent and one of the compounds is a form of aspirin, basically. if I recall it the stent was specifically mentioned in the application. could be covering the form of aspirin they are using. it was filed originally in 2003 BTW.
Interesting that they show the date the notice was mailed. It is a patent related to the 2 drug stent, assigned to Xenogenics.
it is most unusual for their to be an issue date set prior to the actual issuance. I did notice that the entire front page was not posted, just the top half. Looks more like an amendment to the filing date for a provisional that was submitted before. At least to me. But what I think is clearly not important and even if that is the case somebody will be posting that it is a new patent and some people will believe them.
it's just the MCET way....
I bought a couple of years ago at .012. I thought that the liver cells to the pharma market was a good one. then I find out they gave all that away to Corning. I was amazed and felt quite lucky to get out at .022.
MCET is a perfect pump and dump. there is enough "science" to fool the average investor. things like "patents" and 'stem cells" can get the average penny flipper excited. there are lots and lots of misleading posts.
I do think there is some potential but if you look back at message boards from 6 years ago the same sort of thing was going on. However, the price at that time was 20 cents a share.
they really haven't moved anything forward. I thought the trial for MCET-125 was proceeding, but apparently not.
My biggest concern is the authorization of 600 million new shares. I will at least wait until after they are issued and hit the market. it won't be pretty.
then I might wait until after the reverse split, which almost surely will happen.
Based upon current PPS and current revenue ($12,000 last quarter) I expect the PPS to be about half of what it is currently given that the share count will double.
I also don't like intentionally misleading posts....
MCET message boards are rife with them.
Says right there they don't own it. If you read the patent, carefully, you will see that it does not cover any uses, just the isolation protocol.
Just to be clear, MCET does not own the most recent liver stem cell patent, they have a world wide license on a U.S. patent owned by Rhode Island Hospital. how that works, I don't know.
:)
it is a method for isolation of a cell doublet, one cell of which is claimed to be a liver stem cell. This patent has no clear commercial value at this time, though it might in the future.
Well, this isn't stem cell research, it is anti-cancer research, in a flask. The guy is a transplant surgeon, not to say he doesn't know his stuff....
ACTC and Geron are the ones doing stem cell injections into patients, right now, in the USA.
Is this the guy in Toronto dropping the drug on cells in a flask?
http://www.uhn.ca/Focus_of_Care/MOT/Liver/staff_profiles/ghanekar.asp
Keep in mind they did this already for breast cancer several years ago.
"Many a slip twixt the cup and the lip."
5-10 years to the clinic if all goes just exactly perfectly. It didn't for breast cancer.
Does this look familiar, from 2006..
http://www.hotstockmarket.com/forum/thread/14272/mcet-multicell-technologies-inc/120
and 2007
http://www.drugs.com/clinical_trials/multicell-technologies-proprietary-breakthrough-anti-cancer-therapy-shown-prevent-recurrence-cancer-48.html
I agree with what you say and that MCET does have potential. In the near term you need to be very careful as those 600 million additional shares are there, just waiting to be dumped. MCET is not a start up company, they have been around for quite a while. Impressive really how little they have actually accomplished and remain in business. go back and look at the press releases for Sybiol, from 1995. I do get the feeling that dormant MCET is perhaps starting to awake, some good things might be coming down the pike, but I am not going near MCET until those shares are dumped and it is reflected in the PPS. And you know that a couple of years down the road, with those 1.2 billion shares that a reverse split will be the next thing to look out for.
Who is paying for their products? I will state again from their 10Q, $12,330.00 in revenue last quarter. What deals with what big boys? What products?
They gave away the most lucrative part of the cells they had, ADME/TOX to Corning a few years ago and Corning has done nothing with them.
MCET may have some promise but they have done nothing in 6 years. The last in vitro studies were with the same drug six years ago for breast cancer, nothing came of it then, not to say nothing will come of the current studies but a couple of years at least away from animal studies at the very least.
Let's not forget the additional 600 million shares coming very soon. Are you going to say that is not a fact? They are authorized.
I thought the stent might have some promise, then I see the rights were purchased in a foreclosure. if it were any good would somebody going broke give it up for practically nothing? companies are getting out of the stent business.
Good luck if you think anybody outside your little group believes the stuff you post.
I may buy back in at .005, it is coming for sure once those shares are released. i will want to see some sort of progress, not licensed patents of no specific commercial value.
I don't think I will be left behind. Thank you for your concern though!
:)
KittyKat and I will likely be the only sane posters here. MCET is a classic pump and dump and the people getting sucked in have zero understanding of science or how therapies are developed.
If Corning is paying them $750,000 why was their revenue for the last quarter $12,330.00? They gave away the only profitable rights (ADME/Tox) to Corning and have nothing to show for it.
The stent came from a foreclosure sale.
They have no money to run the MCT-125 trial, they say so themselves.
The most recent patent is not owned by them, it is assigned to Rhode Island Hospital. How you get a world wide license on a U.S. patent is beyond me. I expect some DD would show that many of their "patents" are not actually assigned to MCET. This patent has zero commercial value at this time and may not ever.
What everybody seems to be ignoring are the 600 million shares authorized at the shareholders meeting, share count is headed to 1.2 billion, that is just a fact.
they are going to cure cancer? Exactly how? With what? The most recent press release was related to sticking a drug into a tissue culture flask with cancer cells to see what happens, they have no idea. Some fool said they would be in the clinic in two years. I don't think so. But that is still a fact.
If they are lucky enough to get a penny a share that is still just 6 million dollars. You aren't running any trials with that. More likely will go for .005 and net 3 million, just enough to keep them in their salary and doughnuts for the next couple of years.
None of this is opinion, just facts you can look up yourself. Don't worry, I won't post here often. I find the irrational pumping and mis-statements amusing for the most part but the internet is a self policing format.